Clinical data | |
---|---|
Other names | Brophebarbital |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
ChemSpider |
|
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C12H11BrN2O3 |
Molar mass | 311.135 g·mol−1 |
3D model ( JSmol) | |
| |
| |
NY (what is this?) (verify) |
Brophebarbital is a barbiturate derivative. It has sedative and hypnotic effects and is considered to have a moderate abuse potential. [1]
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/ gases |
|
Others/unsorted |
|
Clinical data | |
---|---|
Other names | Brophebarbital |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
ChemSpider |
|
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C12H11BrN2O3 |
Molar mass | 311.135 g·mol−1 |
3D model ( JSmol) | |
| |
| |
NY (what is this?) (verify) |
Brophebarbital is a barbiturate derivative. It has sedative and hypnotic effects and is considered to have a moderate abuse potential. [1]
GABAA |
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAB | |||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic | |||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin | |||||||||||||||||||||||||
Orexin | |||||||||||||||||||||||||
α2δ VDCC | |||||||||||||||||||||||||
Others |
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/ gases |
|
Others/unsorted |
|